SA
CORZ

Shilanski & Associates’s Core Scientific, Inc. Common Stock CORZ Stock Holding History

Shilanski & Associates’s Portfolio CORZ Stock Details CORZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-10,633
Closed -$14K – 225
2022
Q3 		$14K Buy
+10,633
New +$22.6K 0.01% 139

Other funds holding CORZ

PFO
Pathstone Family Office Englewood, New Jersey $13.1B AUM 21.02% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
Comerica Bank
Comerica Bank Dallas, Texas $25.1B AUM 24.68% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
PWM
Perigon Wealth Management San Francisco, California $5.51B AUM 24.51% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
STA
Summit Trail Advisors New York $6.98B AUM 19.51% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return
CCM
Coldstream Capital Management Bellevue, Washington $8.12B AUM 17.95% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return

Shilanski & Associates's CORZ Position: Q4 2022 in Review

Shilanski & Associates sold out of Core Scientific, Inc. Common Stock (CORZ) in Q4 2022, closing a stake of 10,633 shares — an estimated $14K sold.

Shilanski & Associates first reported a position in CORZ in Q3 2022 and held it in 1 quarter. The position peaked at $14K in Q3 2022. 89 funds tracked by Wall St. Rank hold CORZ as of Q4 2022.

  • Shilanski & Associates reported no remaining Core Scientific, Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
  • Shilanski & Associates sold 10,633 Core Scientific, Inc. Common Stock shares in Q4 2022, an estimated $14K.
  • Shilanski & Associates first reported a position in Core Scientific, Inc. Common Stock in Q3 2022 and held it in 1 quarter.
  • Shilanski & Associates's Core Scientific, Inc. Common Stock position peaked at $14K in Q3 2022.
  • 89 funds tracked by Wall St. Rank held Core Scientific, Inc. Common Stock as of Q4 2022.

Based on Shilanski & Associates's 13F filing for Q4 2022, filed 31 Jan 2023.